Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can reduced liver clearance increase progesterone levels?

Reduced liver clearance can increase circulating progesterone, although increased production and other causes may also contribute.

PlausibleNovember 18, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The liver metabolizes progesterone, so reduced hepatic clearance can increase circulating progesterone, although increased production and other causes must also be considered.

laying out figure…
2 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The liver metabolizes progesterone through pathways including CYP3A4-mediated hydroxylation, facilitating its elimination. Men with chronic liver disease have shown higher progesterone levels, but impaired clearance is not necessarily the sole cause, and assay interference can produce an apparent elevation.

Verified conclusion

Progesterone is substantially handled by the liver, making hepatic function a credible determinant of circulating concentrations. In a 26-year-old man, however, an isolated reported elevation requires confirmation and interpretation in the wider endocrine and hepatic context.

Hepatic clearance and clinical evidence

  • Hepatic metabolism is a principal route of progesterone elimination. Reduced hepatic biotransformation therefore has a direct pharmacokinetic basis for increasing circulating progesterone.
  • Clinical findings support this direction: in an older study of men with chronic liver disease, median plasma progesterone was 4.0 nmol/L versus 0.4 nmol/L in healthy male controls, and 72% of affected men exceeded the healthy reference range.
  • This association does not establish impaired clearance as the sole cause. Liver disease can also affect steroid production, protein binding, distribution, and metabolism of concomitant drugs; progesterone concentrations did not clearly correlate with disease severity in the available study.

Mechanistic basis

  • Human liver microsome and recombinant-enzyme data identify CYP3A4 as the most active CYP3A enzyme for progesterone hydroxylation, with lesser roles for CYP3A5 and CYP3A7.
  • Ketoconazole reduced formation of major hydroxylated progesterone metabolites by >90%, supporting a major CYP3A-dependent hepatic pathway. Reduction and subsequent glucuronide or sulfate conjugation also facilitate urinary and biliary elimination.

Interpretation of an elevated result

  • Increased endogenous steroid production is biologically plausible, but male-specific evidence quantifying production-driven true progesterone elevation is limited.
  • Distinguish progesterone from 17-hydroxyprogesterone (17-OHP): they are not interchangeable. For discordant or unexpected results, LC-MS/MS can help exclude immunoassay cross-reactivity.
  • Context-guided assessment may include broader adrenal steroid testing—such as cortisol, DHEA-S, androstenedione, and 17-OHP—rather than inferring congenital adrenal hyperplasia or steroid-producing pathology from one analyte.

Bottom line

  • The claim is well supported: liver metabolism materially contributes to progesterone clearance, and impaired hepatic clearance can raise circulating progesterone; nevertheless, confirmed elevation should also prompt consideration of altered production, steroid-pathway disorders, and analytical artifact.

References

  1. Characterization of Maternal and Fetal CYP3A-Mediated ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. Label: PROGESTERONE injection, solution — dailymed.nlm.nih.gov ↗
  3. Progesterone Capsules (progesterone, USP), 100 mg and 200 mg Rx only — dailymed-us-east-1.awsprod.nlm.nih.gov ↗
  4. Progesterone, prolactin, and gynaecomastia in men with liver ... — pmc.ncbi.nlm.nih.gov ↗
  5. Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Androgen Excess and Deficiency: Analytical and Diagnostic Approaches — academic.oup.com ↗
  7. Accuracy of Two Progesterone Immunoassays for Monitoring In Vitro Fertilization — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan low iron impair thyroid hormone production and T4-to-T3 conversion?→Plausible7 sourcesDoes T3 dose timing affect thyroid panel results?→